Skip to main content
University of Wisconsin–Madison
UW Crest
UW Initiative to End Alzheimer's
Together, we can improve lives and build a future without Alzheimer’s disease — in Wisconsin and beyond.
  • ABOUT Expand Collapse
    • About Us
    • Leadership and Board of Visitors
    • News and Events
    • Subscribe to Our E-newsletter
    • Contact Us
  • WE SUPPORT Expand Collapse
    • Research
    • Education
    • Health Equity
  • MEMORABLE FRIENDS Expand Collapse
    • Why We Give: Featured Friends
    • Become a Memorable Friend
  • WAYS TO GIVE Expand Collapse
    • Ways to Give
    • Donate
  • DONATE
  • UW School of Medicine and Public Health
  1. Home
  2. Tag: lecanembab

lecanembab

Dr. Nathaniel Chin discusses the FDA approval of Leqembi on WPR

Posted on January 12, 2023

Nathaniel Chin, MD, joined host Rob Ferrett on the call-in program “Central Time” on The Ideas Network of Wisconsin Public Radio. Chin discussed the recent FDA approval of the drug Leqembi (lecanemab) to help with early Alzheimer’s and answered callers’ questions.

Posted in NewsTagged Dr. Nathaniel Chin, lecanembab, leqembi

Site footer content

University logo that links to main university website

Quick Links

  • About Us
  • News and Events
  • Memorable Friends
  • Donate

Contact Us

  • University of Wisconsin
    Madison, WI 53703
  • Email: iea@supportuw.org
  • Phone: (608) 308-5167
    • facebook
    • twitter
    • instagram
    • youtube

Website feedback, questions or accessibility issues: iea@medicine.wisc.edu.

Learn more about accessibility at UW–Madison.

This site was built using the UW Theme | Privacy Notice | © 2023 Board of Regents of the University of Wisconsin System.